GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beta Drugs Ltd (NSE:BETA) » Definitions » Scaled Net Operating Assets

Beta Drugs (NSE:BETA) Scaled Net Operating Assets : 0.68 (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Beta Drugs Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Beta Drugs's operating assets for the quarter that ended in Sep. 2024 was ₹2,666 Mil. Beta Drugs's operating liabilities for the quarter that ended in Sep. 2024 was ₹946 Mil. Beta Drugs's Total Assets for the quarter that ended in Mar. 2024 was ₹2,541 Mil. Therefore, Beta Drugs's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.68.


Beta Drugs Scaled Net Operating Assets Historical Data

The historical data trend for Beta Drugs's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beta Drugs Scaled Net Operating Assets Chart

Beta Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 0.71 0.81 0.79 0.72

Beta Drugs Semi-Annual Data
Mar13 Mar14 Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 0.71 0.68 0.60 0.68

Competitive Comparison of Beta Drugs's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Beta Drugs's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beta Drugs's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beta Drugs's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Beta Drugs's Scaled Net Operating Assets falls into.



Beta Drugs Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Beta Drugs's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2024 )
=(Operating Assets (A: Mar. 2024 )-Operating Liabilities (A: Mar. 2024 ))/Total Assets (A: Mar. 2023 )
=(2254.661-822.709)/1984.215
=0.72

where

Operating Assets(A: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2540.986 - 286.325
=2254.661

Operating Liabilities(A: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=969.817 - 60.407 - 86.701
=822.709

Beta Drugs's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Mar. 2024 )
=(2666.19-945.861)/2540.986
=0.68

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2945.062 - 278.872
=2666.19

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1136.457 - 101.731 - 88.865
=945.861

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beta Drugs Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Beta Drugs's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Beta Drugs Business Description

Traded in Other Exchanges
N/A
Address
SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114
Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports them to other countries of which key revenue is derived from the sales made in India.

Beta Drugs Headlines

No Headlines